-
1
-
-
0002629884
-
Atypical antipsychotic drugs
-
Bloom FE, Kupfer DJ, eds. New York: Raven Press
-
Meltzer HY. Atypical antipsychotic drugs. I: Bloom FE, Kupfer DJ, eds. Psychopharmacology: the fourth generation of progress. New York: Raven Press, 1995: 1277-81.
-
(1995)
Psychopharmacology: The Fourth Generation of Progress
, pp. 1277-1281
-
-
Meltzer, H.Y.1
-
2
-
-
0027985726
-
Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test
-
Bertilsson L, Carrillo JA, Dahl ML. Lerena A, Aim C, Bondesson U et al. Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test. Br J Clin Pharmacol 1994; 38: 471-3.
-
(1994)
Br J Clin Pharmacol
, vol.38
, pp. 471-473
-
-
Bertilsson, L.1
Carrillo, J.A.2
Dahl, M.L.3
Lerena, A.4
Aim, C.5
Bondesson, U.6
-
3
-
-
0033397677
-
Cytochrome P450 and therapeutic drug monitoring with respect to clozapine
-
Buur-Rasmussen B, Brøsen K. Cytochrome P450 and therapeutic drug monitoring with respect to clozapine. Eur Neuropsychopharmacol 1999; 9: 453-9.
-
(1999)
Eur Neuropsychopharmacol
, vol.9
, pp. 453-459
-
-
Buur-Rasmussen, B.1
Brøsen, K.2
-
4
-
-
0031048241
-
Will routine therapeutic drug monitoring have a place in clozapine therapy?
-
Freeman DJ, Oyewumi LK. Will routine therapeutic drug monitoring have a place in clozapine therapy? Clin Pharmacokinet 1997; 32: 93-100.
-
(1997)
Clin Pharmacokinet
, vol.32
, pp. 93-100
-
-
Freeman, D.J.1
Oyewumi, L.K.2
-
5
-
-
0031867860
-
Therapeutic drug monitoring of clozapine treatment. Therapeutic threshold value for serum clozapine concentrations
-
Olesen OV. Therapeutic drug monitoring of clozapine treatment. Therapeutic threshold value for serum clozapine concentrations. Clin Pharmacokinet 1998; 34: 497-502.
-
(1998)
Clin Pharmacokinet
, vol.34
, pp. 497-502
-
-
Olesen, O.V.1
-
6
-
-
0028818704
-
Clozapine-induced agranulocytosis. Risk factor, monitoring and management
-
Mendelowitz AJ, Gerson SL, Alvir JMJ, Lieberman JA. Clozapine-induced agranulocytosis. Risk factor, monitoring and management. CNS Drugs 1995; 4: 412-21.
-
(1995)
CNS Drugs
, vol.4
, pp. 412-421
-
-
Mendelowitz, A.J.1
Gerson, S.L.2
Alvir, J.M.J.3
Lieberman, J.A.4
-
7
-
-
0025032064
-
Single- Vs multiple-dose pharmacokinetics of clozapine in psychiatric patients
-
Choc MG, Hsuan F, Honigfeld G, Robinson WT, Ereshefsky L, Crismon ML et al. Single- vs multiple-dose pharmacokinetics of clozapine in psychiatric patients. Pharm Res 1990; 7: 347-51.
-
(1990)
Pharm Res
, vol.7
, pp. 347-351
-
-
Choc, M.G.1
Hsuan, F.2
Honigfeld, G.3
Robinson, W.T.4
Ereshefsky, L.5
Crismon, M.L.6
-
9
-
-
0030939811
-
Fatal acute fulminant liver failure due to clozapine: A case report and review of clozapine-induced hepatotoxicity
-
Macfarlane B, Davies S, Mannan K, Sarsam R, Pariente D, Dooley J. Fatal acute fulminant liver failure due to clozapine: a case report and review of clozapine-induced hepatotoxicity. Gastroenterology 1997; 112: 1707-9.
-
(1997)
Gastroenterology
, vol.112
, pp. 1707-1709
-
-
Macfarlane, B.1
Davies, S.2
Mannan, K.3
Sarsam, R.4
Pariente, D.5
Dooley, J.6
-
10
-
-
0030878680
-
Hepatotoxicity of clozapine
-
Hummer M, Kurz M, Kurzthaler I, Oberbauer H, Miller C, Fleischhacker WW. Hepatotoxicity of clozapine. J Clin Psychopharmacol 1997; 17: 314-7.
-
(1997)
J Clin Psychopharmacol
, vol.17
, pp. 314-317
-
-
Hummer, M.1
Kurz, M.2
Kurzthaler, I.3
Oberbauer, H.4
Miller, C.5
Fleischhacker, W.W.6
|